Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Zutripro Oral Solution Generic Name & Formulations
Legal Class
CII
General Description
Hydrocodone bitartrate 5mg, chlorpheniramine maleate 4mg, pseudoephedrine hydrochloride 60mg; per 5mL; grape-flavor.
Pharmacological Class
Antitussive + antihistamine + sympathomimetic.
How Supplied
Soln—480mL
Manufacturer
Zutripro Oral Solution Indications
Indications
Cough and nasal congestion associated with upper-respiratory allergies or common cold.
Zutripro Oral Solution Dosage and Administration
Adult
Use accurate measuring device. ≥18yrs: 5mL every 4–6hrs as needed. Max: 4 doses (20mL) per 24hrs.
Children
<18yrs: not established.
Zutripro Oral Solution Contraindications
Contraindications
During or within 14 days of MAOIs. Narrow angle glaucoma. Urinary retention. Severe hypertension. Severe coronary artery disease.
Zutripro Oral Solution Boxed Warnings
Boxed Warning
Risks from concomitant use with benzodiazepines or other CNS depressants.
Zutripro Oral Solution Warnings/Precautions
Warnings/Precautions
Risks from concomitant benzodiazepines or other CNS depressants (see Interactions). Discontinue if respiratory depression occurs. Abuse potential (monitor). Avoid in head injury, other intracranial lesions or pre-existing increase in intracranial pressure. Acute abdomen. Cardiovascular disorders. Diabetes. Thyroid disorders. Addison's disease. Prostatic hypertrophy. Urethral stricture. Asthma. Severe hepatic or renal impairment. Elderly. Labor & delivery. Pregnancy (Cat.C). Nursing mothers: not recommended.
Zutripro Oral Solution Pharmacokinetics
See Literature
Zutripro Oral Solution Interactions
Interactions
See Contraindications. Increased risk of respiratory depression, sedation with benzodiazepines or other CNS depressants (eg, opioids, antihistamines, antipsychotics, anxiolytics, alcohol); avoid. Hypertensive crisis with MAOIs. May affect or be affected by TCAs. Paralytic ileus may occur with anticholinergics
Zutripro Oral Solution Adverse Reactions
Adverse Reactions
Sedation, somnolence, mental clouding, lethargy, impairment of mental and physical performance, anxiety, fear, dysphoria, dizziness, psychic dependence, mood changes, nervousness or sleeplessness, visual disturbances, confusion, headache, euphoria, facial dyskinesia, feeling faint, lightheadedness, agitation, restlessness, insomnia, irritability, tremor; respiratory depression, cardiovascular effects.
Zutripro Oral Solution Clinical Trials
See Literature
Zutripro Oral Solution Note
Not Applicable
Zutripro Oral Solution Patient Counseling
See Literature
